Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elisabeth Brouwer

Showing results (71-80 of 216) with videos related to

Pageof 22
Sort By:
International Journal of Environmental Research and Public Health|April 3, 2021
Effect of Anti-Rheumatic Treatment on the Periodontal Condition of Rheumatoid Arthritis PatientsMenke J de Smit, Johanna Westra, Marcel D Posthumus, et al.
Clinical and Experimental Rheumatology|March 24, 2015
Patient-tailored dose reduction of TNF-α blocking agents in ankylosing spondylitis patients with stable low disease activity in daily clinical practiceSuzanne Arends, Eveline van der Veer, Fleur B S Kamps, et al.
Plos One|April 25, 2018
Ankylosing spondylitis disease activity score is related to NSAID use, especially in patients treated with TNF-α inhibitorsMarlies J G Carbo, Anneke Spoorenberg, Fiona Maas, et al.
Rheumatology (Oxford, England)|July 12, 2019
High angiopoietin-2 levels associate with arterial inflammation and long-term glucocorticoid requirement in polymyalgia rheumaticaYannick van Sleen, Annemieke M H Boots, Wayel H Abdulahad, et al.
Clinical and Experimental Rheumatology|February 18, 2016
Radiographic vertebral fractures develop in patients with ankylosing spondylitis during 4 years of TNF-α blocking therapyFiona Maas, Anneke Spoorenberg, Elisabeth Brouwer, et al.
The Journal of Rheumatology|March 17, 2017
Ultrasound Evaluation of the Entheses in Daily Clinical Practice during Tumor Necrosis Factor-α Blocking Therapy in Patients with Ankylosing SpondylitisFréke Wink, George A Bruyn, Fiona Maas, et al.
Cancer Immunology, Immunotherapy : CII|March 17, 2018
Enhanced expression of PD-1 and other activation markers by CD4+ T cells of young but not old patients with metastatic melanomaRob R H van den Brom, Kornelis S M van der Geest, Elisabeth Brouwer, et al.
The Journal of Rheumatology|January 17, 2017
Detailed Analysis of the Articular Domain in Patients with Primary Sjögren SyndromeRada V Moerman, Suzanne Arends, Petra M Meiners, et al.
Rheumatology (Oxford, England)|February 27, 2019
Markers of angiogenesis and macrophage products for predicting disease course and monitoring vascular inflammation in giant cell arteritisYannick van Sleen, Maria Sandovici, Wayel H Abdulahad, et al.
Autoimmunity Reviews|May 6, 2018
Positron emission tomography (PET) and single photon emission computed tomography (SPECT) imaging of macrophages in large vessel vasculitis: Current status and future prospectsWilliam Febry Jiemy, Peter Heeringa, Jan A A M Kamps, et al.
Pageof 22

Showing results (71-80 of 216) with videos related to

Sort By:
Pageof 22
International Journal of Environmental Research and Public Health|April 3, 2021
Effect of Anti-Rheumatic Treatment on the Periodontal Condition of Rheumatoid Arthritis PatientsMenke J de Smit, Johanna Westra, Marcel D Posthumus, et al.
Clinical and Experimental Rheumatology|March 24, 2015
Patient-tailored dose reduction of TNF-α blocking agents in ankylosing spondylitis patients with stable low disease activity in daily clinical practiceSuzanne Arends, Eveline van der Veer, Fleur B S Kamps, et al.
Plos One|April 25, 2018
Ankylosing spondylitis disease activity score is related to NSAID use, especially in patients treated with TNF-α inhibitorsMarlies J G Carbo, Anneke Spoorenberg, Fiona Maas, et al.
Rheumatology (Oxford, England)|July 12, 2019
High angiopoietin-2 levels associate with arterial inflammation and long-term glucocorticoid requirement in polymyalgia rheumaticaYannick van Sleen, Annemieke M H Boots, Wayel H Abdulahad, et al.
Clinical and Experimental Rheumatology|February 18, 2016
Radiographic vertebral fractures develop in patients with ankylosing spondylitis during 4 years of TNF-α blocking therapyFiona Maas, Anneke Spoorenberg, Elisabeth Brouwer, et al.
The Journal of Rheumatology|March 17, 2017
Ultrasound Evaluation of the Entheses in Daily Clinical Practice during Tumor Necrosis Factor-α Blocking Therapy in Patients with Ankylosing SpondylitisFréke Wink, George A Bruyn, Fiona Maas, et al.
Cancer Immunology, Immunotherapy : CII|March 17, 2018
Enhanced expression of PD-1 and other activation markers by CD4+ T cells of young but not old patients with metastatic melanomaRob R H van den Brom, Kornelis S M van der Geest, Elisabeth Brouwer, et al.
The Journal of Rheumatology|January 17, 2017
Detailed Analysis of the Articular Domain in Patients with Primary Sjögren SyndromeRada V Moerman, Suzanne Arends, Petra M Meiners, et al.
Rheumatology (Oxford, England)|February 27, 2019
Markers of angiogenesis and macrophage products for predicting disease course and monitoring vascular inflammation in giant cell arteritisYannick van Sleen, Maria Sandovici, Wayel H Abdulahad, et al.
Autoimmunity Reviews|May 6, 2018
Positron emission tomography (PET) and single photon emission computed tomography (SPECT) imaging of macrophages in large vessel vasculitis: Current status and future prospectsWilliam Febry Jiemy, Peter Heeringa, Jan A A M Kamps, et al.
Pageof 22